FSM Wealth Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Buy
4,421
+192
+5% +$36.1K 0.09% 124
2026
Q1
$834K Buy
4,229
+133
+3% +$25.6K 0.11% 110
2025
Q4
$753K Buy
4,096
+333
+9% +$58.4K 0.1% 112
2025
Q3
$577K Buy
3,763
+314
+9% +$47.5K 0.08% 155
2025
Q2
$480K Sell
3,449
-111
-3% -$15.6K 0.08% 160
2025
Q1
$523K Buy
3,560
+389
+12% +$56.3K 0.12% 102
2024
Q4
$424K Buy
3,171
+102
+3% +$14.3K 0.1% 111
2024
Q3
$478K Buy
3,069
+94
+3% +$15.2K 0.13% 96
2024
Q2
$464K Sell
2,975
-80
-3% -$12K 0.16% 89
2024
Q1
$414K Buy
3,055
+21
+0.7% +$2.78K 0.15% 98
2023
Q4
$409K Sell
3,034
-139
-4% -$18.1K 0.17% 96
2023
Q3
$430K Buy
3,173
+167
+6% +$22.8K 0.22% 86
2023
Q2
$390K Buy
3,006
+810
+37% +$119K 0.2% 99
2023
Q1
$305K Buy
2,196
+569
+35% +$76.6K 0.18% 116
2022
Q4
$221K Buy
+1,627
New +$204K 0.16% 130

Other funds holding AZN